News & Insights  |  Media Mentions

Related Professionals

Practice Areas

Contact

Patricia O'Connell
Senior Communications Manager
202.719.4532
poconnell@wileyrein.com

Brian Sylvester Discusses Upcoming USDA-FDA Meeting on Oversight for Cell-Based Meats

Inside Health Policy’s FDA Week
September 14, 2018

Brian P. Sylvester, special counsel in Wiley Rein’s Food, Drug, and Medical Device Law and Consumer Product Regulation practices, was quoted by Inside Health Policy’s FDA Week in a September 13 article about next month’s joint meeting of the U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) to discuss oversight of the cell-based meat industry.

The meeting, announced by the USDA and FDA on September 10, will focus on potential hazards, regulatory issues, and labeling of the emerging technology, according to the article. The announcement came on the heels of a letter sent to the White House by the North American Meat Institute and food technology company Memphis Meats, calling for the two agencies to share oversight of the industry.  

Mr. Sylvester, a former USDA regulatory lawyer, told Inside Health Policy he thinks the meeting is a signal that the FDA and USDA are breaking bread over the cell-based meat question.

“The announcement of the upcoming joint FDA-USDA meeting is a welcome development given the turf battle that appeared to be brewing between the two agencies over the past several months,” Mr. Sylvester said. “This signals that the agencies are looking forward to partnering with one another and with industry to facilitate the commercialization of cell-based meat technology sooner rather than later.”

To read the article, click here (subscription required).